<DOC>
	<DOCNO>NCT01119443</DOCNO>
	<brief_summary>Bioequivalence PPX ER 1.5 mg x 1 tablet q.d . 0.375 mg PPX ER x 4 tablet q.d . fast fed condition Food effect 1.5 mg ER x 1 tablet q.d .</brief_summary>
	<brief_title>Bioequivalence Pramipexole Extended Release ( PPX ER ) 1.5mg x 1 Tablet Once Daily ( q.d . ) vs. PPX ER 0.375mg x 4 Tablets Under Fasted Fed Conditions Japanese Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Pramipexole</mesh_term>
	<criteria>Inclusion criterion : Japanese healthy male 20 40 year age body mass index ( BMI ) 17.6 26.4 kg/m2 ( BMI calculation : weight kilogram divide square height meter ) Exclusion criterion : 1 . Any clinical relevance finding medical examination follow 1 . Blood pressure ( systolic blood pressure low 110 mmHg diastolic blood pressure low 60 mmHg screen either supine sit position ) , 2. pulse rate , 3. electrocardiogram [ ECG ] 4. laboratory test parameter ) clinical relevance 2 . Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder 3 . Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder 4 . History orthostatic hypotension , faint spell blackouts 5 . Chronic acute infection</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>